• HSP90 Modulates RNA Foci in Myotonic Dystrophy Type 1 Myobla

  2026-07-02

  This study used an unbiased small molecule screen to uncover HSP90 as a novel regulator of DMPK mRNA expression and RNA foci formation in Myotonic Dystrophy type 1 (DM1) cells. These findings clarify the molecular mechanisms of DM1 pathogenesis and highlight new directions for therapeutic intervention.

• GTP Solution (100 mM): Foundation for mRNA Synthesis & Signa

  2026-07-01

  GTP Solution (100 mM) enables high-fidelity in vitro transcription and is essential for synthesizing functional mRNA, as demonstrated in recent bladder cancer research. Its ≥99% purity and stringent contaminant control make it optimal for sensitive applications. This article reviews its mechanistic role, application benchmarks, and integration into advanced molecular workflows.

• Arrb2-Mediated M2 Macrophage Polarization Reduces Liver IRI

  2026-07-01

  This study elucidates a novel hepatocyte-intrinsic mechanism where Arrb2 upregulates 6-ketoLCA, promoting M2 macrophage polarization and thereby mitigating hepatic ischemia–reperfusion injury (IRI). These findings offer new insight into immunomodulatory pathways that could improve liver transplantation outcomes.

• Ruxolitinib (INCB018424): Protocols and Innovations in JAK-S

  2026-06-30

  Ruxolitinib (INCB018424) is redefining myeloproliferative disorder research through high-dimensional immune profiling and combinatorial immunomodulation. This article synthesizes advanced protocol guidance, key troubleshooting insights, and the latest innovations in spectral cytometry—empowering researchers to unlock new frontiers in JAK-STAT pathway inhibition.

• Triacetin in Biochemical Research: Workflows, Use-Cases & Op

  2026-06-30

  Triacetin (glyceryl triacetate) stands out as a versatile lipid-related biochemical reagent, enabling advanced metabolic and antitumor assays with precise dosing and robust safety margins. This guide delivers protocol-ready workflows, troubleshooting strategies, and a translation of the latest mechanistic insights to maximize reproducibility and impact in life science research.

• CX-5461: Mechanistic Insights and Strategic Assay Design in

  2026-06-29

  Explore the multifaceted role of CX-5461 as a potent RNA polymerase I inhibitor in cancer research. This article reveals unique mechanistic insights, advanced protocol guidance, and practical applications, offering a deeper perspective for designing high-impact studies.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Innova

  2026-06-29

  This study establishes intravesical delivery of p21 mRNA-loaded lipid nanoparticles as a potent tumor suppressor replacement strategy for non-muscle-invasive bladder cancer. The findings demonstrate robust restoration of p21 expression, suppression of tumor growth, and minimal systemic toxicity, highlighting a clinically relevant approach for localized mRNA-based cancer therapy.

• Tranexamic Acid as an Antifibrinolytic Agent: Workflows & In

  2026-06-28

  Tranexamic Acid is redefining antifibrinolytic research with robust clot-stabilization and infection-control capabilities, as demonstrated in advanced bi-layer wound dressings. Leveraging high-purity APExBIO Tranexamic Acid enables reproducible protocols and translational insights for trauma and wound care models.

• LY2603618: Precision Chk1 Inhibition for Biomarker-Guided Ca

  2026-06-27

  Explore the advanced application of LY2603618, a selective Chk1 inhibitor, as a DNA damage response tool in biomarker-guided cancer research. This article uniquely examines PPP2R2A as a predictive marker, offering fresh, actionable insights beyond standard protocols.

• Cy5.5 NHS Ester: Advanced Near-Infrared Dye for In Vivo Imag

  2026-06-26

  Cy5.5 NHS ester (non-sulfonated) empowers precise protein and nanoparticle labeling, enabling high-sensitivity near-infrared fluorescence imaging for in vivo applications. This article details protocol enhancements, troubleshooting, and translational applications—such as blood-brain barrier-crossing nanoparticles—anchored in the latest research.

• High-Throughput In Vitro BBB Permeability Prediction Model

  2026-06-26

  This study introduces a robust high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells in a Transwell system, with integrated correction for lysosomal trapping. The model demonstrates reliable prediction of CNS drug permeability, streamlining early-stage screening and de-risking central nervous system (CNS) drug development.

• GTP Solution (100 mM): Enabling Precision mRNA Synthesis & T

  2026-06-25

  Explore how GTP Solution (100 mM) empowers high-fidelity mRNA synthesis and advances tumor suppressor research in bladder cancer. This cornerstone article reveals mechanisms, protocol parameters, and unique insights not covered elsewhere.

• Indole-3-pyruvic Acid Feedback Regulates Auxin Biosynthesis

  2026-06-25

  This study reveals that indole-3-pyruvic acid (IPA) acts as a negative feedback inhibitor of TAA1, coordinating the two-step auxin biosynthesis pathway in plants. These findings clarify a central regulatory mechanism for indole-3-acetic acid (IAA) homeostasis, with implications for plant hormone research and metabolic engineering.

• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-06-24

  This study pioneers a combinatorial library of ROS-degradable lipid nanoparticles to selectively deliver mRNA into tumor cells, exploiting the elevated ROS environment for targeted release and gene expression. Key findings demonstrate that the BAmP-TK-12 lipid formulation enables potent, tumor-specific mRNA delivery and effective blockade of mutant RAS signaling, offering a new paradigm for advancing mRNA-based cancer therapeutics.

• 3X (DYKDDDDK) Peptide: Precision Affinity Tag for Structure-

  2026-06-23

  Explore how the 3X (DYKDDDDK) Peptide advances high-sensitivity protein tagging and enables robust structure-function studies. This article reveals unique mechanistic insights, practical assay implications, and scientific context beyond standard purification workflows.

14777 records 3/986 page Previous Next 12345 下5页 Last page